Am. J. Respir. Crit. Care Med., Volume 163, Number 4, March 2001, 924-929

Clinical Predictors of Health-related Quality of Life Depend on Asthma Severity

MARILYN L. MOY, ELLIOT ISRAEL, SCOTT T. WEISS, ELIZABETH F. JUNIPER, LOUISE DUBÉ, JEFFREY M. DRAZEN, and the NHLBI Asthma Clinical Research Network

Division of Pulmonary and Critical Care Medicine and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Clinical Epidemiology and Biostatistics, McMaster University Medical Center, Hamilton, Ontario, Canada; and Abbott Laboratories, Abbott Park, Illinois

The National Asthma Education and Prevention Program guidelines define asthma severity before treatment by lung function and symptoms. It has been assumed, but not demonstrated, that improvement in these measures would translate into improvement in health-related quality of life (HRQL). Because HRQL is an important outcome in asthma management, we asked what are the determinants of HRQL? To address this question, we retrospectively analyzed HRQL data, as measured by the Juniper Asthma Quality of Life Questionnaire, in subjects with mild versus moderate-severe asthma from two clinical trials. We examined whether these traditional clinical outcomes have different relationships to HRQL depending on asthma severity. We also assessed whether the relationship between clinical outcomes and HRQL in subjects with moderate-severe asthma would change when subjects improved to mild-moderate disease with controller medication treatment. Lung function was not an independent predictor or determinant of HRQL at any level of asthma severity, whereas intensity of shortness of breath predicted HRQL at all levels of asthma severity. Rescue -agonist use independently predicted HRQL in subjects with mild asthma, but not in those with moderate-severe asthma. In subjects with moderate-severe asthma who improved to mild-moderate disease with controller treatment, rescue -agonist use predicted HRQL. We conclude that the independent determinants of HRQL vary according to asthma severity and change with asthma treatment.

This article has been cited by other articles:

				B C.T. Flapper, H M Koopman, C ten Napel, and C P van der Schans Psychometric properties of the TACQOL-asthma, a disease-specific measure of health related quality-of-life for children with asthma and their parents Chronic Respiratory Disease, April 1, 2006; 3(2): 65 - 72. [Abstract] [PDF]

				Endpoints in asthma drug trials - what do they mean? DTB, March 1, 2006; 44(3): 21 - 24. [Abstract] [Full Text] [PDF]

				A. Ekici, M. Ekici, E. Kurtipek, H. Keles, T. Kara, M. Tunckol, and P. Kocyigit Association of Asthma-Related Symptoms With Snoring and Apnea and Effect on Health-Related Quality of Life Chest, November 1, 2005; 128(5): 3358 - 3363. [Abstract] [Full Text] [PDF]

				M. L. Garcia Garcia, U. Wahn, L. Gilles, A. Swern, C. A. Tozzi, and P. Polos Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study Pediatrics, August 1, 2005; 116(2): 360 - 369. [Abstract] [Full Text] [PDF]

				O. Oguzturk, A. Ekici, M. Kara, M. Ekici, M. Arslan, A. Iteginli, T. Kara, and E. Kurtipek Psychological Status and Quality of Life in Elderly Patients With Asthma Psychosomatics, February 1, 2005; 46(1): 41 - 46. [Abstract] [Full Text] [PDF]

				D. Bumbacea, D. Campbell, L. Nguyen, D. Carr, P.J. Barnes, D. Robinson, and K.F. Chung Parameters associated with persistent airflow obstruction in chronic severe asthma Eur. Respir. J., July 1, 2004; 24(1): 122 - 128. [Abstract] [Full Text] [PDF]

				L.G. Pont, T. van der Molen, P. Denig, G.T. van der Werf, and F.M. Haaijer-Ruskamp Relationship between guideline treatment and health-related quality of life in asthma Eur. Respir. J., May 1, 2004; 23(5): 718 - 722. [Abstract] [Full Text] [PDF]

				S S Birring, B Prudon, A J Carr, S J Singh, M D L Morgan, and I D Pavord Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ) Thorax, April 1, 2003; 58(4): 339 - 343. [Abstract] [Full Text] [PDF]

				R. Buhl, G. Hanf, M. Soler, G. Bensch, J. Wolfe, F. Everhard, K. Champain, H. Fox, and J. Thirlwell The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma Eur. Respir. J., November 1, 2002; 20(5): 1088 - 1094. [Abstract] [Full Text] [PDF]

				J. Zhang, C. Yu, S.T. Holgate, and T.F. Reiss Variability and lack of predictive ability of asthma end-points in clinical trials Eur. Respir. J., November 1, 2002; 20(5): 1102 - 1109. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF]